Rhenman & Partners Asset Management AB Diversified Active

CIK: 0001599882 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: Apr 19, 2016

Total Value ($000): $503,761 (100.0% shares, 0.0% debt)

Holdings (92)

Alexion Pharmaceuticals Inc 3.3%
Value ($000) $16,846 Shares 121,000 Est. Cost $160.08 Unrealized
GILD Gilead Sciences Inc 3.3%
Value ($000) $16,535 Shares 180,000 Est. Cost $64.82 Unrealized -2.1%
BMRN BioMarin Pharmaceutical Inc 3.1%
Value ($000) $15,671 Shares 190,000 Est. Cost $86.90 Unrealized -6.4%
PFE Pfizer Inc 2.8%
Value ($000) $14,079 Shares 475,000 Est. Cost $20.45 Unrealized -8.6%
LLY Eli Lilly & Co 2.8%
Value ($000) $14,042 Shares 195,000 Est. Cost $58.70 Unrealized +9.0%
ALKS Alkermes Plc 2.7%
Value ($000) $13,847 Shares 405,000 Est. Cost $45.76 Unrealized -13.7%
INCY Incyte Corp Ltd 2.4%
Value ($000) $12,320 Shares 170,000 Est. Cost $71.96 Unrealized +3.6%
Celgene Corp 2.4%
Value ($000) $12,011 Shares 120,000 Est. Cost $111.51 Unrealized
Abiomed Inc 2.4%
Value ($000) $11,851 Shares 125,000 Est. Cost $74.57 Unrealized
Allergan Plc 2.2%
Value ($000) $11,257 Shares 42,000 Est. Cost $302.63 Unrealized
CVS CVS Health Corp 2.2%
Value ($000) $10,892 Shares 105,000 Est. Cost $67.72 Unrealized +6.9%
MDT Medtronic Plc 2.0%
Value ($000) $10,275 Shares 137,000 Est. Cost $58.05 Unrealized +1.5%
St Jude Medical Inc 2.0%
Value ($000) $9,900 Shares 180,000 Est. Cost $64.52 Unrealized
BIIB Biogen Inc 2.0%
Value ($000) $9,892 Shares 38,000 Est. Cost $264.15 Unrealized 0.0%
ZBH Zimmer Biomet Hgs Inc 1.9%
Value ($000) $9,703 Shares 91,000 Est. Cost $91.33 Unrealized -2.3%
Cigna Corp 1.9%
Value ($000) $9,470 Shares 69,000 Est. Cost $135.02 Unrealized
BMY Bristol Myers Squibb Co 1.8%
Value ($000) $9,071 Shares 142,000 Est. Cost $39.46 Unrealized +13.5%
Laboratory Corp of America Hgs 1.7%
Value ($000) $8,785 Shares 75,000 Est. Cost $121.84 Unrealized
CNC Centene Corp 1.7%
Value ($000) $8,725 Shares 141,712 Est. Cost $30.22 Unrealized -1.2%
Medivation Inc 1.7%
Value ($000) $8,598 Shares 187,000 Est. Cost $53.83 Unrealized
Walgreens Boots Alliance Inc 1.7%
Value ($000) $8,424 Shares 100,000 Est. Cost $85.15 Unrealized
HCA HCA Holdings Inc 1.6%
Value ($000) $8,117 Shares 104,000 Est. Cost $70.94 Unrealized -8.5%
ALNY Alnylam Pharmaceuticals Inc 1.6%
Value ($000) $7,846 Shares 125,000 Est. Cost $82.00 Unrealized -18.9%
PRGO Perrigo Co Plc 1.5%
Value ($000) $7,804 Shares 61,000 Est. Cost $165.12 Unrealized -17.2%
UNH United Health Group Inc 1.5%
Value ($000) $7,734 Shares 60,000 Est. Cost $89.16 Unrealized +13.2%
CAH Cardinal Health Inc 1.5%
Value ($000) $7,539 Shares 92,000 Est. Cost $60.16 Unrealized +1.7%
Aetna Inc 1.5%
Value ($000) $7,527 Shares 67,000 Est. Cost $104.69 Unrealized
ABBV AbbVie Inc 1.5%
Value ($000) $7,426 Shares 130,000 Est. Cost $37.54 Unrealized -1.1%
Endo International Plc 1.5%
Value ($000) $7,319 Shares 260,000 Est. Cost $48.55 Unrealized
Express Scripts Hg Co 1.4%
Value ($000) $7,281 Shares 106,000 Est. Cost $81.84 Unrealized
Nektar Therapeutics 1.4%
Value ($000) $7,219 Shares 525,000 Est. Cost $11.22 Unrealized
AMGN Amgen Inc 1.3%
Value ($000) $6,747 Shares 45,000 Est. Cost $112.46 Unrealized -1.5%
ELV Anthem Inc 1.3%
Value ($000) $6,533 Shares 47,000 Est. Cost $134.01 Unrealized -13.0%
MCK McKesson Corp 1.2%
Value ($000) $6,290 Shares 40,000 Est. Cost $191.15 Unrealized -21.7%
VRTX Vertex Pharmaceuticals Inc 1.2%
Value ($000) $6,200 Shares 78,000 Est. Cost $102.25 Unrealized -11.5%
Cooper Companies Inc (The) 1.2%
Value ($000) $6,159 Shares 40,000 Est. Cost $171.80 Unrealized
COR AmerisourceBergen Corp 1.1%
Value ($000) $5,453 Shares 63,000 Est. Cost $63.28 Unrealized +4.7%
DXCM Dexcom Inc 1.0%
Value ($000) $5,093 Shares 75,000 Est. Cost $12.76 Unrealized +30.9%
Cepheid Inc 1.0%
Value ($000) $5,004 Shares 150,000 Est. Cost $38.84 Unrealized
HUM Humana Inc 1.0%
Value ($000) $4,940 Shares 27,000 Est. Cost $170.02 Unrealized -5.8%
EW Edwards Lifesciences Corp 1.0%
Value ($000) $4,852 Shares 55,000 Est. Cost $20.87 Unrealized +32.2%
Cerner Corp 0.9%
Value ($000) $4,555 Shares 86,000 Est. Cost $61.66 Unrealized
Keryx Biopharmaceuticals Inc 0.9%
Value ($000) $4,437 Shares 950,000 Est. Cost $6.26 Unrealized
ZELTIQ Aesthetics Inc 0.9%
Value ($000) $4,346 Shares 160,000 Est. Cost $29.38 Unrealized
REGN Regeneron Pharmaceuticals Inc 0.9%
Value ($000) $4,325 Shares 12,000 Est. Cost $378.17 Unrealized +8.4%
CYH Community Health Syst Inc 0.8%
Value ($000) $4,165 Shares 225,000 Est. Cost $26.36 Unrealized -42.1%
SUPN Supernus Pharmaceuticals Inc 0.8%
Value ($000) $4,118 Shares 270,000 Est. Cost $8.32 Unrealized +56.7%
HALO Halozyme Therapeutics Inc 0.8%
Value ($000) $4,082 Shares 431,000 Est. Cost $16.27 Unrealized -42.2%
JAZZ Jazz Pharmaceuticals Plc 0.8%
Value ($000) $3,917 Shares 30,000 Est. Cost $170.18 Unrealized -26.9%
Ariad Pharmaceuticals Inc 0.8%
Value ($000) $3,834 Shares 600,000 Est. Cost $6.68 Unrealized
BDX Becton Dickinson & Co 0.8%
Value ($000) $3,796 Shares 25,000 Est. Cost $118.02 Unrealized +3.5%
LIVN Livanova Plc 0.8%
Value ($000) $3,779 Shares 70,000 Est. Cost $60.40 Unrealized -8.0%
Endologix Inc 0.7%
Value ($000) $3,637 Shares 435,000 Est. Cost $12.10 Unrealized
Horizon Pharma Plc 0.7%
Value ($000) $3,314 Shares 200,000 Est. Cost $20.29 Unrealized
Radius Health Inc 0.7%
Value ($000) $3,301 Shares 105,000 Est. Cost $31.44 Unrealized
Intra-Cellular Therapies Inc 0.6%
Value ($000) $3,197 Shares 115,000 Est. Cost $19.23 Unrealized
Heartware Intl Inc 0.6%
Value ($000) $3,142 Shares 100,000 Est. Cost $47.88 Unrealized
OMCL Omnicell Inc 0.6%
Value ($000) $3,066 Shares 110,000 Est. Cost $31.17 Unrealized -11.9%
Lion Biotechnologies Inc 0.6%
Value ($000) $3,048 Shares 600,000 Est. Cost $8.39 Unrealized
Cempra Inc 0.6%
Value ($000) $2,996 Shares 171,000 Est. Cost $33.87 Unrealized
Revance Therapeutics Inc 0.6%
Value ($000) $2,968 Shares 170,000 Est. Cost $25.76 Unrealized
Dynavax Technologies Corp 0.6%
Value ($000) $2,886 Shares 150,000 Est. Cost $20.77 Unrealized
PODD Insulet Corp 0.5%
Value ($000) $2,719 Shares 82,000 Est. Cost $34.93 Unrealized -10.1%
XNCR Xencor Inc 0.5%
Value ($000) $2,684 Shares 200,000 Est. Cost $14.41 Unrealized -17.9%
EXEL Exelixis Inc 0.5%
Value ($000) $2,600 Shares 650,000 Est. Cost $5.20 Unrealized -18.6%
IONS Ionis Pharmaceuticals Inc 0.5%
Value ($000) $2,592 Shares 64,000 Est. Cost $53.96 Unrealized -24.7%
Chimerix Inc 0.5%
Value ($000) $2,555 Shares 500,000 Est. Cost $11.04 Unrealized
ESPR Esperion Therapeutics Inc 0.5%
Value ($000) $2,537 Shares 150,000 Est. Cost $20.34 Unrealized -20.9%
RARE Ultragenyx Pharmaceutical Inc 0.5%
Value ($000) $2,532 Shares 40,000 Est. Cost $65.43 Unrealized 0.0%
FibroGen Inc 0.5%
Value ($000) $2,427 Shares 114,000 Est. Cost $25.32 Unrealized
NBIX Neurocrine Biosciences Inc 0.5%
Value ($000) $2,373 Shares 60,000 Est. Cost $39.68 Unrealized 0.0%
MGNX Macrogenics Inc 0.4%
Value ($000) $2,250 Shares 120,000 Est. Cost $25.43 Unrealized -25.1%
Portola Pharmaceuticals Inc 0.4%
Value ($000) $2,142 Shares 105,000 Est. Cost $35.25 Unrealized
PCRX Pacira Pharmaceuticals Inc 0.4%
Value ($000) $2,119 Shares 40,000 Est. Cost $56.86 Unrealized +2.9%
HOLX Hologic Inc 0.4%
Value ($000) $2,070 Shares 60,000 Est. Cost $29.00 Unrealized +20.3%
Achillion Pharmaceuticals Inc 0.4%
Value ($000) $2,054 Shares 266,000 Est. Cost $9.71 Unrealized
Tandem Diabetes Care Inc 0.4%
Value ($000) $1,820 Shares 209,000 Est. Cost $12.69 Unrealized
Rigel Pharmaceuticals Inc 0.4%
Value ($000) $1,768 Shares 850,000 Est. Cost $3.57 Unrealized
Catabasis Pharmaceuticals Inc 0.3%
Value ($000) $1,739 Shares 345,100 Est. Cost $10.91 Unrealized
Anthera Pharmaceuticals Inc 0.3%
Value ($000) $1,575 Shares 435,000 Est. Cost $3.60 Unrealized
ACAD Acadia Pharmaceuticals Inc 0.3%
Value ($000) $1,398 Shares 50,000 Est. Cost $25.97 Unrealized -15.9%
Tetraphase Pharmaceuticals Inc 0.3%
Value ($000) $1,389 Shares 300,000 Est. Cost $17.20 Unrealized
Regulus Therapeutic Inc 0.3%
Value ($000) $1,386 Shares 200,000 Est. Cost $6.54 Unrealized
Valeant Pharm Intl Inc 0.3%
Value ($000) $1,315 Shares 50,000 Est. Cost $101.65 Unrealized
Nevro Corp 0.2%
Value ($000) $1,125 Shares 20,000 Est. Cost $56.25 Unrealized
Array BioPharma Inc 0.2%
Value ($000) $1,092 Shares 370,000 Est. Cost $4.79 Unrealized
Mirati Therapeutics Inc 0.2%
Value ($000) $1,070 Shares 50,000 Est. Cost $31.48 Unrealized
Avalanche Biotechnologies Inc 0.2%
Value ($000) $796 Shares 154,006 Est. Cost $23.02 Unrealized
Orexigen Therapeutics Inc 0.1%
Value ($000) $675 Shares 1,200,000 Est. Cost $5.13 Unrealized
OCUL Ocular Therapeutix Inc 0.1%
Value ($000) $386 Shares 40,000 Est. Cost $7.57 Unrealized 0.0%
BIND Therapeutics Inc 0.1%
Value ($000) $294 Shares 133,535 Est. Cost $11.18 Unrealized
Threshold Pharmaceuticals 0.0%
Value ($000) $93 Shares 201,537 Est. Cost $4.08 Unrealized